Business Wire

NV-VERACODE

1.8.2024 13:56:35 CEST | Business Wire | Press release

Share
As Developers Struggle to Prioritize Security Debt, Veracode Announces Latest Innovations to Identify and Unify Critical Risk

Black Hat USA Conference (booth #2536) – Veracode, a global leader in application risk management, today announced platform innovations to help organizations uncover, prioritize, and reduce security debt across their growing attack surface. Universal Connector and Application Security Heatmap, the two newest capabilities from Longbow powered by Veracode, allow organizations to quickly connect findings from any source and see the applications that are contributing to the most risk. Together, the Universal Connector and the Application Security Heatmap provide clear, operational insight into assets and issues, allowing remediation actions to be prioritized by quantifiable risk.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240801020287/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Figure 1: State of Software Security 2024 Language Snapshot (Graphic: Business Wire)

“The combination of mounting security debt, an expanding attack surface made more vulnerable by generative AI, and an overwhelming volume of security alerts makes it challenging for organizations to know which application risks to prioritize,” said Chris Eng, Chief Research Officer at Veracode. “In fact, our State of Software Security research shows that many organizations are more focused on remediating low-severity flaws than critical flaws. Security leaders need technology that enables them to effectively uncover and manage application risk, and then reduce that risk by focusing on the issues that matter most across their entire attack surface.”

Prioritization of Security Debt: Critical vs Non-critical

In its State of Software Security 2024 Language Snapshot, Veracode revealed the varying prevalence of “critical” and “non-critical” security debt among applications written in different languages. Critical security debt is defined for this report as high-severity flaws that remain unfixed for longer than a year. If exploited, these flaws would put the integrity and availability of organizations at serious risk.

The research found that while most security debt exists in first-party code written by in-house developers, the most critical security debt resides in third-party code (e.g., open-source software imported into the codebase). For example, 80 percent of critical debt in Java apps, and 63 percent in JavaScript apps, is in third-party code. The report also found about 51 percent of critical flaws in Java apps turn into security debt, while only about 45 percent of low to medium flaws progress into security debt.

Eng said, “With the overflowing volume of security flaws, developers are not prioritizing those that present the most risk. While focusing on non-critical flaws may result in some quick fixes, developers should use their limited capacity to work on fixing critical flaws with the highest potential impact on security.”

Putting Visibility and Prioritization First: Universal Connector & Application Security Heatmap

Building on Veracode’s acquisition of Longbow Security in April this year, and the introduction of Longbow’s Repo Risk Visibility and Analysis capability in May, Universal Connector and Application Security Heatmap are designed with developers’ time in mind. The capabilities provide operational oversight to help developers and security teams quickly identify and prioritize the most important fixes for growing security debt across their applications.

Universal Connector allows organizations to quickly access disparate source data they otherwise couldn’t bring into the Longbow platform, meaning they don’t have to wait for a tool-specific connector. The Application Security Heatmap maps the application back to the owner and shows a 90-day risk trend, as well as enabling customization of the risk threshold to meet organizational policy. Application security teams and developers can analyze each application, view the distribution of risk, and implement recommendations for the Best Next Action™ to remediate that risk.

“As organizations seek to find and fix mounting critical security debt, the need for risk-focused visibility and prioritization is clear,” said Derek Maki, Vice President of Product Management at Veracode. “The new capabilities in the Longbow platform provide our customers with a deeper understanding of an organization’s riskiest applications, plus the unique ability to identify the top five most impactful solutions for improvement.”

Enhanced by the Longbow acquisition, Veracode closes the gap between development and security teams, delivering visibility from code repositories to cloud assets and runtime. Longbow also identifies infrastructure-as-code and misconfiguration risk for cloud assets originating from repositories.

The Longbow Universal Connector and Application Security Heatmap are available immediately. For more information, please visit the website or watch the interview with Brian Roche, Veracode Chief Executive Officer, and Derek Maki.

The full State of Software Security 2024 Language Snapshot is available on the Veracode website.

Visitors to the Black Hat USA Conference, August 3-8, 2024, can learn more about Veracode’s platform and these new features by visiting Veracode’s booth #2536 for a demo.

About the State of Software Security Report

The Veracode State of Software Security 2024 report analyzed data from large and small companies, commercial software suppliers, software outsourcers, and open-source projects. The research draws from more than a million (1,007,133) applications across all scan types, 1,553,022 dynamic analysis scans, and 11,429,365 static analysis scans. All those scans produced 96 million raw static findings, 4 million raw dynamic findings, and 12.2 million raw software composition analysis findings.

About Veracode

Veracode is a global leader in Application Risk Management for the AI era. Powered by trillions of lines of code scans and a proprietary AI-assisted remediation engine, the Veracode platform is trusted by organizations worldwide to build and maintain secure software from code creation to cloud deployment. Thousands of the world’s leading development and security teams use Veracode every second of every day to get accurate, actionable visibility of exploitable risk, achieve real-time vulnerability remediation, and reduce their security debt at scale. Veracode is a multi-award-winning company offering capabilities to secure the entire software development life cycle, including Veracode Fix, Static Analysis, Dynamic Analysis, Software Composition Analysis, Container Security, Application Security Posture Management, and Penetration Testing.

Learn more at www.veracode.com, on the Veracode blog, and on LinkedIn and X.

Copyright © 2024 Veracode, Inc. All rights reserved. Veracode is a registered trademark of Veracode, Inc. in the United States and may be registered in certain other jurisdictions. All other product names, brands or logos belong to their respective holders. All other trademarks cited herein are property of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240801020287/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release

REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release

In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release

- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release

Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye